EPIZYME, INC. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 53 rows, 53 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-06-05: Reporting owner KERINS PATRICK J; Form 4; Security Series B Preferred Stock; Transaction C Conversion of derivative security.
- 2013-06-05: Reporting owner DRANT RYAN D; Form 4; Security Series B Preferred Stock; Transaction C Conversion of derivative security.
- 2013-06-05: Reporting owner KOLLURI KRISHNA KITTU; Form 4; Security Series B Preferred Stock; Transaction C Conversion of derivative security.
- 2013-06-05: Reporting owner BASKETT FOREST; Form 4; Security Series B Preferred Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-06-05 | KERINS PATRICK J 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −16,899,721 0 owned after | no price filed | 2013-06-07 | |
| 2013-06-05 | DRANT RYAN D 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −16,899,721 0 owned after | no price filed | 2013-06-07 | |
| 2013-06-05 | KOLLURI KRISHNA KITTU 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −16,899,721 0 owned after | no price filed | 2013-06-07 | |
| 2013-06-05 | BASKETT FOREST 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −16,899,721 0 owned after | no price filed | 2013-06-07 | |
| 2013-06-05 | BARRIS PETER J 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −16,899,721 0 owned after | no price filed | 2013-06-07 | |
| 2013-06-05 | SANDELL SCOTT D 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −16,899,721 0 owned after | no price filed | 2013-06-07 | |
| 2013-06-05 | BARRETT M JAMES 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −16,899,721 0 owned after | no price filed | 2013-06-07 | |
| 2013-06-05 | Viswanathan Ravi 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −16,899,721 0 owned after | no price filed | 2013-06-07 | |
| 2013-06-05 | Weller Harry R 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −16,899,721 0 owned after | no price filed | 2013-06-07 | |
| 2013-06-05 | MOTT DAVID M Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −16,899,721 0 owned after | no price filed | 2013-06-07 | |
| 2013-06-05 | NEW ENTERPRISE ASSOCIATES 13 LP | NEA 13 GP, Ltd | NEA Partners 13, Limited Partnership 10% Owner | 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Direct | C Conversion of derivative security | −16,899,721 0 owned after | no price filed | 2013-06-07 | |
| 2013-06-05 | GOLDFISCHER CARL Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −10,280,288 0 owned after | $0.00 | 2013-06-07 | |
| 2013-06-05 | GOLDFISCHER CARL Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −195,904 0 owned after | $0.00 | 2013-06-07 | |
| 2013-06-05 | Bay City Capital Fund V Co-Investment Fund, L.P. | Bay City Capital Management V LLC | Bay City Capital Fund V, L.P. | BAY CITY CAPITAL LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Footnotes | C Conversion of derivative security | −10,280,288 0 owned after | $0.00 | 2013-06-07 | |
| 2013-06-05 | Bay City Capital Fund V Co-Investment Fund, L.P. | Bay City Capital Management V LLC | Bay City Capital Fund V, L.P. | BAY CITY CAPITAL LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Footnotes | C Conversion of derivative security | −195,904 0 owned after | $0.00 | 2013-06-07 | |
| 2013-06-05 | KPCB XIII Associates, LLC | KLEINER PERKINS CAUFIELD & BYERS XIII, LLC 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Direct | C Conversion of derivative security | −6,462,918 0 owned after | $0.00 | 2013-06-07 | |
| 2013-06-05 | KPCB XIII Associates, LLC | KLEINER PERKINS CAUFIELD & BYERS XIII, LLC 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Direct | C Conversion of derivative security | −6,217,335 0 owned after | $0.00 | 2013-06-07 | |
| 2013-06-05 | SEIDENBERG BETH C Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −6,462,918 0 owned after | $0.00 | 2013-06-07 | |
| 2013-06-05 | SEIDENBERG BETH C Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −6,217,335 0 owned after | $0.00 | 2013-06-07 | |
| 2013-06-05 | Astellas Venture Fund I L.P. | Astellas Venture Management LLC 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Direct | C Conversion of derivative security | −1,904,762 0 owned after | $0.00 | 2013-06-06 | |
| 2013-06-05 | Vander Vort John | MPM BioVentures IV GP LLC | MPM BioVentures IV GmbH & Co. Beteiligungs KG | MPM BioVentures IV LLC | MPM BioVentures IV QP LP | Foley Todd | MPM Asset Management Investors BV4 LLC | KAILIAN VAUGHN M | Scopa James Paul | MPM BioVentures IV Strategic Fund, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −6,930,000 0 owned after | no price filed | 2013-06-06 | |
| 2013-06-05 | Vander Vort John | MPM BioVentures IV GP LLC | MPM BioVentures IV GmbH & Co. Beteiligungs KG | MPM BioVentures IV LLC | MPM BioVentures IV QP LP | Foley Todd | MPM Asset Management Investors BV4 LLC | KAILIAN VAUGHN M | Scopa James Paul | MPM BioVentures IV Strategic Fund, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −1,176,472 0 owned after | no price filed | 2013-06-06 | |
| 2013-06-05 | EVNIN LUKE | GADICKE ANSBERT 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −6,930,000 0 owned after | no price filed | 2013-06-06 | |
| 2013-06-05 | EVNIN LUKE | GADICKE ANSBERT 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −1,176,472 0 owned after | no price filed | 2013-06-06 | |
| 2013-06-05 | Celgene European Investment Co LLC | CELGENE CORP /DE/ 10% Owner | 10% Owner | 4 | Series C Preferred Stock Derivative · Direct | C Conversion of derivative security | −9,803,922 0 owned after | $0.00 | 2013-06-06 | |
| 2013-06-05 | Amgen Ventures LLC | AMGEN INC 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Direct | C Conversion of derivative security | −952,381 0 owned after | $0.00 | 2013-06-05 | |
| 2013-05-30 holding as of filing | Horvitz H Robert 10% Owner | 3 | Series A Preferred Stock Derivative · Direct | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | Astellas Venture Fund I L.P. | Astellas Venture Management LLC 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Direct | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | SEIDENBERG BETH C Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See Footnotes | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | SEIDENBERG BETH C Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Footnotes | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | KPCB XIII Associates, LLC | KLEINER PERKINS CAUFIELD & BYERS XIII, LLC 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Direct | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | KPCB XIII Associates, LLC | KLEINER PERKINS CAUFIELD & BYERS XIII, LLC 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Direct | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | GOLDFISCHER CARL Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | GOLDFISCHER CARL Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | BAY CITY CAPITAL LLC | Bay City Capital Fund V, L.P. | Bay City Capital Fund V Co-Investment Fund, L.P. | Bay City Capital Management V LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Footnotes | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | BAY CITY CAPITAL LLC | Bay City Capital Fund V, L.P. | Bay City Capital Fund V Co-Investment Fund, L.P. | Bay City Capital Management V LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Footnotes | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | AMGEN INC | Amgen Ventures LLC 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Direct | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | Celgene European Investment Co LLC | CELGENE CORP /DE/ 10% Owner | 10% Owner | 3 | Series C Preferred Stock Derivative · Direct | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | BARRETT M JAMES 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | BARRIS PETER J 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | BASKETT FOREST 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | DRANT RYAN D 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | KERINS PATRICK J 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | KOLLURI KRISHNA KITTU 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | MOTT DAVID M Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | SANDELL SCOTT D 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | Viswanathan Ravi 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | Weller Harry R 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | NEW ENTERPRISE ASSOCIATES 13 LP | NEA Partners 13, Limited Partnership | NEA 13 GP, Ltd 10% Owner | 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Direct | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | Vander Vort John | MPM BioVentures IV LLC | MPM Asset Management Investors BV4 LLC | MPM BioVentures IV GP LLC | MPM BioVentures IV Strategic Fund, L.P. | MPM BioVentures IV QP LP | KAILIAN VAUGHN M | MPM BioVentures IV GmbH & Co. Beteiligungs KG | Foley Todd | Scopa James Paul 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | Vander Vort John | MPM BioVentures IV LLC | MPM Asset Management Investors BV4 LLC | MPM BioVentures IV GP LLC | MPM BioVentures IV Strategic Fund, L.P. | MPM BioVentures IV QP LP | KAILIAN VAUGHN M | MPM BioVentures IV GmbH & Co. Beteiligungs KG | Foley Todd | Scopa James Paul 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | GADICKE ANSBERT | EVNIN LUKE 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2013-05-30 | ||
| 2013-05-30 holding as of filing | GADICKE ANSBERT | EVNIN LUKE 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2013-05-30 |